Alnylam Pharmaceuticals Inc
F:DUL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alnylam Pharmaceuticals Inc
F:DUL
|
US |
|
A
|
Asics Corp
OTC:ASCCF
|
JP |
|
L
|
LyondellBasell Industries NV
XBER:DLY
|
UK |
|
Cryoport Inc
NASDAQ:CYRX
|
US |
|
D
|
Daimler Truck Holding AG
XMUN:DTG
|
DE |
|
H
|
HAL Trust
OTC:HALFF
|
MC |
|
F
|
Fresenius SE & Co KGaA
DUS:FRE
|
DE |
|
Northam Platinum Holdings Ltd
F:7JR
|
ZA |
|
F
|
Fortuna Silver Mines Inc
BMV:FVIN
|
CA |
|
Mueller Die lila Logistik SE
F:MLL
|
DE |
|
3
|
3M Co
F:MMM
|
US |
|
E
|
Exelon Corp
BMV:EXC
|
US |
|
D
|
Daikin Industries Ltd
F:DKI
|
JP |
|
Vaudoise Assurances Holding SA
SIX:VAHN
|
CH |
|
P
|
PTC Therapeutics Inc
F:P91
|
US |
Wall St Price Targets
DUL Price Targets Summary
Alnylam Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for DUL is 383.46 EUR with a low forecast of 201 EUR and a high forecast of 501.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DUL's stock price target?
Price Target
383.46
EUR
According to Wall Street analysts, the average 1-year price target for DUL is 383.46 EUR with a low forecast of 201 EUR and a high forecast of 501.14 EUR.
What is the Revenue forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 17%.
What is the Operating Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
36%
The compound annual growth rate for Operating Income over the next 8 years is 36%.
What is the Net Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
41%
The compound annual growth rate for Net Income over the next 8 years is 41%.
